Adrenomedullin—A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin

REFERENCES

• Santolaya ME, Alvarez AM, Avil′es CL, et al. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Pediatr Infect Dis J. 2007;26:794–798.
   PubMed Web of Science ®Google Scholar
• Paganini HR, Aguirre C, Puppa G, et al. A prospective multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer. 2007;109:2572–2579.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Phillips R, Alexander S, et al; International Pediatric Fever and Neutropenia Guideline Panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30:4427–4438
   PubMed Web of Science ®Google Scholar
• Karakurt DG, Demirsoy U, Corapcioglu F, et al. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients? Pediatr Hematol Oncol. 2014;31:415–424.
   PubMed Web of Science ®Google Scholar
• Phillips RS, Wade R, Lehrnbecher T, et al. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med. 2012;10:6.
   PubMed Web of Science ®Google Scholar
• Semeraro M, Thomée C, Rolland E, et al. A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatr Blood Cancer. 2010;54:284–290.
   PubMed Web of Science ®Google Scholar
• Haeusler GM, Carlesse F, Phillips RS. An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer. Pediatr Infect Dis J. 2013;32:e390–e396.
   PubMed Web of Science ®Google Scholar
• Kim DY, Lee YS, Ahn S, et al. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat. 2011;43:176–180.
   PubMed Web of Science ®Google Scholar
• Ahn S, Lee YS. Predictive factors for poor prognosis febrile neutropenia. Curr Opin Oncol. 2012;24:376–380.
   PubMed Web of Science ®Google Scholar
• von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–544.
   PubMed Web of Science ®Google Scholar
• Mian A, Becton D, Saylors R, et al. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study. Pediatr Blood Cancer. 2012;59:238–245.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Morgenthaler NG, et al. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium. 2007;14:345–351.
   PubMed Web of Science ®Google Scholar
• Temmesfeld-Wollbrück B, Hocke AC, Suttorp N, Hippenstiel S. Adrenomedullin and endothelial barrier function. Thromb Haemost. 2007;98:944–951.
   PubMed Web of Science ®Google Scholar
• Al Shuaibi M, Bahu RR, Chaftari AM, et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013;56:943–950.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427–431.
   PubMed Web of Science ®Google Scholar
• Goldstein B, Giroir A, Randolph A. An international consensus conference on Pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8
   PubMedGoogle Scholar
• Christ-Crain M, Morgenthaler NG, Struck J, et al. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9:R816–R824.
   PubMed Web of Science ®Google Scholar
• Suberviola B, Castellanos-Ortega A, Ruiz Ruiz A, et al. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med. 2013;39:1945–1952.
   PubMed Web of Science ®Google Scholar
• Hagag AA, Elmahdy HS, Ezzat AA. Prognostic value of plasma pro-adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr. 2011;48:471–473.
   PubMed Web of Science ®Google Scholar
• Secmeer G, Devrim I, Kara A, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007;29:107–111.
   PubMed Web of Science ®Google Scholar
• Lin SG, Hou TY, Huang DH, et al. Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia–a systemic review and meta-analysis. Pediatr Infect Dis J. 2012;31:e182–e188.
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–217.
   PubMed Web of Science ®Google Scholar
• Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003.
   PubMed Web of Science ®Google Scholar